<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abnormal activation of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> translocator protein (TSPO) contributes to arrhythmogenesis during cardiac metabolic compromise; however, its role in the antiarrhythmic activities of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0005039'>hypoxia</z:mp> adaptation remains unclear </plain></SENT>
<SENT sid="1" pm="."><plain>Our results demonstrated that 80% of normoxic rats developed ischaemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>, whereas this condition was seldom observed in rats with 14 days of <z:hpo ids='HP_0011010'>chronic</z:hpo> intermittent hypobaric <z:mp ids='MP_0005039'>hypoxia</z:mp> (CIHH) </plain></SENT>
<SENT sid="2" pm="."><plain>TSPO stimulation or inhibition affected the <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> incidence in normoxic rats, but did not change the CIHH-mediated antiarrhythmic effects </plain></SENT>
<SENT sid="3" pm="."><plain>Abrupt and excessive elevation of TSPO activity was positively linked to ischaemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>, and CIHH preserved TSPO activity during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The preservation of TSPO activity by CIHH also contributed to the maintenance of intracellular Ca homeostasis </plain></SENT>
<SENT sid="5" pm="."><plain>These results suggest that the blunt sensitivity of TSPO to ischaemic stress may be responsible for the antiarrhythmic effects by CIHH </plain></SENT>
</text></document>